Tequin to be Pulled from the Market

Pulaski Law Firm is no longer accepting claims related to the use of Tequin.

On May 1, 2006, Bristol-Myers Squibb stated that it will cease making and selling its antibiotic Tequin. Tequin has been linked to serious cases of diabetes and other potentially fatal blood sugar abnormalities. According to a Canadian study that was supposed to appear in the New England Journal of Medicine in March, Tequin users had 17 times greater risk of developing serious diabetes and 4 times greater risk of being hospitalized with low blood sugar complications than patients using other antibiotics. Tequin (generic: gatifloxacin) received FDA approval in 1999. Consumer group Public Citizen stated that there have been 388 patients with blood-sugar irregularities linked with Tequin since January 1, 2000. Those cases included 20 deaths and 159 hospitalizations. The consumer group and various physicians called for the drug’s withdrawal, claiming it carries great health risks but few benefits over similar drugs.

Canadian Study

In March, 2006 the results of a Canadian study were released which showed that Tequin was linked to serious cases of diabetes and other blood sugar disorders. These results were set to appear in the March 30, 2006 New England Journal of Medicine but were released early due to the life threatening nature of the side effects. Based on the study’s alarming findings, the author, Dr. David Juurlink of the Sunnybrook and Women’s College Health Sciences Center in Toronto, questioned whether the drug should be immediately removed from the market. Other prominent physicians believed that a black box warning should be added to Tequin’s warning label.

Warning for Diabetics May Apply to Anyone Taking Tequin

In early 2006, Bristol Myers Squibb and the FDA added a warning to the drug’s label notifying diabetics not to take Tequin. However, the study’s author said the blood-sugar problem can happen to anybody whether they have diabetes or not, and it usually occurs within a few days of taking the drug. The risk of the drug might be even greater than the study revealed because it was only based on hospital data. If a patient suffered these side effects but wasn’t hospitalized, or died, they would not have been included in the study data.

What is Tequin?

Tequin is an antibiotic that is commonly used to treat adults with lung, sinus and urinary tract infections as well as certain sexually transmitted diseases. Tequin is an antibiotic in the class of drugs called fluoroquinolones, which also contains Cipro, Levaquin and Avelox. This study indicated that a risk of diabetes was specific to Tequin and was not a problem with the entire class of drugs. However, the entire class of drugs had been linked to tendon ruptures.

Legal Help for Tequin Users

If you or a loved one took Tequin and suffered from diabetes, hyperglycemia, hypoglycemia, or other blood sugar side effects, contact Pulaski Law Firm for a free, no-obligation Tequin consultation today. Fill out the form at the right or call 1-800-BAD-DRUG (1-800-223-3784).

Pulaski Law Firm is no longer accepting claims related to the use of Tequin.

– See more at: https://www.1800baddrug.com/_prescription-drug-cases/tequin.php#sthash.0OP72y4c.dpuf

Tequin Lawyer, Tequin Attorney
5 (100%) 2 votes